AUA Releases Guideline on Diagnosis and Treatment of Overactive Bladder

June 2013
American Family Physician;6/1/2013, Vol. 87 Issue 11, p800
Academic Journal
This article discusses the American Urological Association (AUA) recommendations for the diagnosis and treatment of non-neurogenic overactive bladder. Physicians should document signs and symptoms of overactive bladder, take a patient history, and perform physical examination and urinalysis. Behavioral therapies should be offered as first-line therapy. Second-line therapies for overactive bladder include oral antimuscarinics, fesoterodine and oxybutynin.


Related Articles

  • Take Home Message: Female Urology/lncontinence/ Urodynamics. Brucker, Benjamin M. // AUANews;Oct2016 Supplement Annual Meeting Highlights Female Urology/Inco 

    A reprint of an article related to female urology/incontinence/ urodynamics published in a journal of American Urological Association, as of October 2016. It states an announcement made by Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction at the 2016 AUA annual meeting...

  • Don't Allow Overactive Bladder to Compromise Your Quality of Life.  // Women's Health Advisor;Aug2014, Vol. 18 Issue 8, p4 

    The article discusses the causes of overactive bladder (OAB) in women and also mentions that behavioral modifications and medications can reduce the symptoms of urinary urgency and frequency. Topics discussed include role of neurological disorders such as Parkinson's disease and bladder cancer...

  • A Decade of Pharmacotherapy for Overactive Bladder: What Have We Learned? Wein, Alan J. // AUANews;Oct2015 Supplement Annual Meeting Highlights Overactice Bladder, 

    The article presents information on the American Urological Association's 2015 Annual Meeting held in New Orleans, Louisiana. The topics discussed during the season included origin of the term overactive bladder (OAB), difficulties in evaluation of OAB, and the range of antimuscarinic products...

  • A Case-Based Approach for Overactive Bladder to Evaluate and Implement Successful Treatment Strategies. Ellsworth, Pamela // Journal of Managed Care Medicine;2014, Vol. 17 Issue 1, p10 

    No abstract available.

  • Health Policy at the AUA Annual Meeting. Schlossberg, Steven // AUANews;Jul2011, Vol. 16 Issue 7, p13 

    The article discusses the highlights of the meeting of the American Urological Association's Health Policy committee held during the AUA 106th annual meeting in Washington, D.C. in May 2011. The committee's presentations at the meeting highlighted the Annual Health Update, as well as the...

  • OnabotulinumtoxinA for Idiopathic Overactive Bladder. Rovner, Eric S.; Koski, Michelle // AUANews;Oct2012, p25 

    The article discusses onabotulinumtoxinA or Botox as a possible option for idiopathic overactive bladder. It references the study "OnabotulinumtoxinA for Urinary Incontinence in Patients With Idiopathic Overactive Bladder: Results of a Phase 3 Pivotal Trial" by V. W. Nitti, presented at the May...

  • AUA Guideline on Diagnosis and Treatment of Overactive Bladder in Adults. Gormley, E. Ann // AUANews;May2012, Vol. 17 Issue 5, p17 

    In the article, the author discusses the American Urological Association (AUA) guideline on the diagnosis and treatment of overactive bladder (OAB) in adults. In 2009, the AUA created the OAB Guideline Panel to develop a clinical framework for practitioners who diagnose and treat nonneurogenic...

  • AUA Foundation Launches Public Awareness Campaign about Overactive Bladder. Sheppard, Michael T. // AUANews;May2012, Vol. 17 Issue 5, p20 

    The article reports on the "It's Time To Talk About OAB" campaign that is due to be launched by the American Urological Association (AUA) Foundation during the AUA meeting in Atlanta, Georgia in 2012. The aim of the initiative is to raise awareness about the overactive bladder (OAB) condition....

  • Refractory OAB with Prolapse. Gormley, E. Ann; Vasavada, Sandip // AUANews;Sep2015, Vol. 20 Issue 9, p8 

    The article discusses the cause of overactive bladder (OAB) from pelvic organ prolapse (POP) which occur due to myogenic and neurogenic changes. Topics discussed include improvement of OAB with surgical correction, the American Urological Association (AUA)/SUFU guidelines for treatment of OAB...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics